Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01100684 · ClinicalTrials.gov registry record · Phase 3
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A Phase 3 study, sponsored by Tioga Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 611
- Enrollment target
NCT01100684: Completed Phase 3 study, sponsored by Tioga Pharmaceuticals.
NCT01100684 is a Phase 3 study that has completed, run by Tioga Pharmaceuticals. The registered enrollment target is 611 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (21% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01100684, a Phase 3 study, has completed, sponsored by Tioga Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 611 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether asimadoline is safe and effective at treating D-IBS.
Primary Outcome
A study responder is a subject who has both a decrease from baseline of IBS-related abdominal pain and a decrease from baseline of daily bowel movements
Interventions
- DRUG Placebo
- DRUG Asimadoline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 611 participants |
| Start Date | 2010-05 |
| Est. Completion | 2013-06 |
| Phase | Phase 3 |
What the finished NCT01100684 record still lists
NCT01100684 is an interventional study that assigns participants to a tested intervention. The registered 611 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (21% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01100684 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01100684 about?
NCT01100684 is a clinical study titled "Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)". The purpose of this study is to determine whether asimadoline is safe and effective at treating D-IBS.
What is the current status of trial NCT01100684?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 611 participants. The study started on 2010-05. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01100684?
The interventions under investigation include: Placebo (DRUG), Asimadoline (DRUG).
Who is sponsoring clinical trial NCT01100684?
This trial is sponsored by Tioga Pharmaceuticals, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01100684's enrollment target sits among peer trials
611 600th of 2000 higher than 1,400 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04224493 · 612 participants · Phase 3
A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.
- NCT04590326 · 612 participants · Phase 1
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
- NCT06266416 · 612 participants · NA
IMARA for Black Male Caregivers and Girls Empowerment (IMAGE)
- NCT03536312 · 610 participants · NA
Treatment in Thoracic Aortic Aneurysm: Surgery vs Surveillance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia